155 related articles for article (PubMed ID: 25114322)
1. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
[TBL] [Abstract][Full Text] [Related]
2. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
Unemo M; Golparian D; Potočnik M; Jeverica S
Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
[TBL] [Abstract][Full Text] [Related]
3. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
[TBL] [Abstract][Full Text] [Related]
4. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
Unemo M; Golparian D; Hestner A
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
[TBL] [Abstract][Full Text] [Related]
6. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
[TBL] [Abstract][Full Text] [Related]
7. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.
Korting HC; Abeck D
Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
[TBL] [Abstract][Full Text] [Related]
9. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
[TBL] [Abstract][Full Text] [Related]
10. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.
Unemo M; Golparian D; Syversen G; Vestrheim DF; Moi H
Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144442
[TBL] [Abstract][Full Text] [Related]
11. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
[TBL] [Abstract][Full Text] [Related]
12. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
Rice LB
Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
[No Abstract] [Full Text] [Related]
13. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
[TBL] [Abstract][Full Text] [Related]
14. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae.
Golden MR; Barbee LA; Kerani R; Dombrowski JC
Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259
[TBL] [Abstract][Full Text] [Related]
15. [Ceftriaxone as a single-dose treatment for male gonococcal urethritis].
Urabe S; Shigematsu S
Jpn J Antibiot; 1984 Nov; 37(11):2169-73. PubMed ID: 6098709
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands.
de Vries HJ; van der Helm JJ; Schim van der Loeff MF; van Dam AP
Euro Surveill; 2009 Sep; 14(37):. PubMed ID: 19761737
[TBL] [Abstract][Full Text] [Related]
17. Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study.
van Amerongen R; Gazendam RP; van Bergen JEAM
BMC Fam Pract; 2019 Jan; 20(1):12. PubMed ID: 30646849
[TBL] [Abstract][Full Text] [Related]
18. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea.
Mogabgab WJ; Lutz FB
South Med J; 1994 Apr; 87(4):461-4. PubMed ID: 8153771
[TBL] [Abstract][Full Text] [Related]
19. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.
Unemo M; Golparian D; Stary A; Eigentler A
Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601
[TBL] [Abstract][Full Text] [Related]
20. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
Hustig A; Bell C; Waddell R
Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
